<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02770768</url>
  </required_header>
  <id_info>
    <org_study_id>IRB16-0087</org_study_id>
    <nct_id>NCT02770768</nct_id>
  </id_info>
  <brief_title>Effects of Flibanserin on the Pre- and Post-menopausal Female Brain</brief_title>
  <official_title>Flibanserin and Women With Hypoactive Sexual Desire Disorder: A Double-Blind, Randomized, Electrical Neuroimaging Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the present study is to understand the neurobiological mechanisms of action&#xD;
      underlying sexual desire building on prior work Dr. Stephanie Cacioppo has done in which&#xD;
      desire was not manipulated. In the present project, Dr. Stephanie Cacioppo is manipulating&#xD;
      desire through Flibanserin (Addyi) vs. placebo and she will be measuring subjective sexual&#xD;
      desire as a manipulation check. The investigators will address this goal using a double-blind&#xD;
      randomized outpatient design and determine the pre-post neurobehavioral change in the&#xD;
      Flibanserin group and investigate the extent to which Flibanserin normalizes brain activity&#xD;
      in premenopausal women with HSDD and the extent to which regional brain activation is&#xD;
      associated with changes in symptoms and behavior (as measured with self-report measures of&#xD;
      sexual desire and/or eye-tracking movements).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypoactive sexual desire disorder (HSDD) is the most common sexual complaint in women. Over&#xD;
      the past 8 years, Dr. Stephanie Cacioppo has developed and validated the Desire Intention&#xD;
      task, in which individuals are instructed to indicate as rapidly and as accurately as&#xD;
      possible whether or not each visually presented stimulus (e.g., attractive persons of the&#xD;
      opposite sex) is sexually desirable to them at the moment of the experiment. Flibanserin&#xD;
      (Addyi) is a new medication approved by the FDA for the treatment of HSDD in pre-menopausal&#xD;
      women. The investigators propose a study using the DIT to determine the extent to which&#xD;
      Flibanserin normalizes brain activity in women with HSDD and the extent to which regional&#xD;
      brain activation is associated with changes in symptoms and behavior.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">December 21, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 21, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>EEG Results: Evoked Brain Potentials (measured brain response that is the direct result of a specific cognitive event)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change from baseline EEG results at 8 weeks. Average the electrical brain activity evoked by each type of stimuli to calculate the evoked brain potentials (any stereotyped electrophysical response to a stimulus).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Eye movement tracking: movements to first saccades</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change from baseline eye movement tracking results at 8 weeks.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hypoactive Sexual Desire Disorder</condition>
  <arm_group>
    <arm_group_label>Flibanserin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug: Flibanserin&#xD;
8 weeks&#xD;
100mg once daily at bedtime</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Drug: Matching Placebo Matching placebo capsules taken in same amount of pills as the active medication (for 8 weeks once daily at bedtime)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Flibanserin</intervention_name>
    <description>Observational study using electroencephalogram (EEG) and eye movement tracking device at baseline, week 4, and week 8 while subjects are taking either Flibanserin or matching placebo.</description>
    <arm_group_label>Flibanserin</arm_group_label>
    <other_name>Addyi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Observational study using electroencephalogram (EEG) and eye movement tracking device at baseline, week 4, and week 8 while subjects are taking either Flibanserin or matching placebo.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Matching placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female&#xD;
&#xD;
          -  Ages 21-45 or 51-74&#xD;
&#xD;
          -  Pre- or Postmenopausal&#xD;
&#xD;
          -  DSM-5 diagnosis of hypoactive sexual desire disorder (HSDD)&#xD;
&#xD;
          -  Right-handed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Male&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Nursing women&#xD;
&#xD;
          -  Post-menopausal women&#xD;
&#xD;
          -  Women who report not being able to stop drinking alcohol during the duration of the&#xD;
             study&#xD;
&#xD;
          -  Currently taking psychotropic medication&#xD;
&#xD;
          -  History of seizures or neurological disorders&#xD;
&#xD;
          -  Under hormonal therapy&#xD;
&#xD;
          -  Current or past diagnosis of cancer&#xD;
&#xD;
          -  Any unstable medical illnesses&#xD;
&#xD;
          -  Lifetime history of bipolar disorder, schizophrenia, or psychotic disorder&#xD;
&#xD;
          -  Current or recent (past 3 months) substance abuse or dependence&#xD;
&#xD;
          -  Current or recent (past 3 months) clinical depression&#xD;
&#xD;
          -  Currently taking any medications that have/may have unfavorable interactions with&#xD;
             Flibanserin&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephanie Cacioppo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jon E Grant, MD, JD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bianchi-Demicheli F, Cojan Y, Waber L, Recordon N, Vuilleumier P, Ortigue S. Neural bases of hypoactive sexual desire disorder in women: an event-related FMRI study. J Sex Med. 2011 Sep;8(9):2546-59. doi: 10.1111/j.1743-6109.2011.02376.x. Epub 2011 Jun 30.</citation>
    <PMID>21718449</PMID>
  </reference>
  <reference>
    <citation>Bolmont M, Cacioppo JT, Cacioppo S. Love is in the gaze: an eye-tracking study of love and sexual desire. Psychol Sci. 2014 Sep;25(9):1748-56. doi: 10.1177/0956797614539706. Epub 2014 Jul 16.</citation>
    <PMID>25031302</PMID>
  </reference>
  <reference>
    <citation>Cacioppo S, Bianchi-Demicheli F, Frum C, Pfaus JG, Lewis JW. The common neural bases between sexual desire and love: a multilevel kernel density fMRI analysis. J Sex Med. 2012 Apr;9(4):1048-54. doi: 10.1111/j.1743-6109.2012.02651.x. Epub 2012 Feb 21.</citation>
    <PMID>22353205</PMID>
  </reference>
  <reference>
    <citation>Cacioppo S, Cacioppo JT. Dynamic spatiotemporal brain analyses using high-performance electrical neuroimaging, Part II: A step-by-step tutorial. J Neurosci Methods. 2015 Dec 30;256:184-97. doi: 10.1016/j.jneumeth.2015.09.004. Epub 2015 Sep 10.</citation>
    <PMID>26363189</PMID>
  </reference>
  <reference>
    <citation>Cacioppo S, Couto B, Bolmont M, Sedeno L, Frum C, Lewis JW, Manes F, Ibanez A, Cacioppo JT. Selective decision-making deficit in love following damage to the anterior insula. Curr Trends Neurol. 2013;7:15-19.</citation>
    <PMID>25382944</PMID>
  </reference>
  <reference>
    <citation>Cacioppo S, Weiss RM, Runesha HB, Cacioppo JT. Dynamic spatiotemporal brain analyses using high performance electrical neuroimaging: theoretical framework and validation. J Neurosci Methods. 2014 Dec 30;238:11-34. doi: 10.1016/j.jneumeth.2014.09.009. Epub 2014 Sep 20.</citation>
    <PMID>25244954</PMID>
  </reference>
  <reference>
    <citation>Ortigue S, Bianchi-Demicheli F. The chronoarchitecture of human sexual desire: a high-density electrical mapping study. Neuroimage. 2008 Nov 1;43(2):337-45. doi: 10.1016/j.neuroimage.2008.07.059. Epub 2008 Aug 13.</citation>
    <PMID>18761412</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>April 22, 2016</study_first_submitted>
  <study_first_submitted_qc>May 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2016</study_first_posted>
  <last_update_submitted>January 15, 2021</last_update_submitted>
  <last_update_submitted_qc>January 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HSDD (Hypoactive Sexual Desire Disorder)</keyword>
  <keyword>EEG (Electroencephalogram)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypokinesia</mesh_term>
    <mesh_term>Sexual Dysfunctions, Psychological</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

